ARVINAS, INC. Shares Outstanding
ARVINAS, INC. (ARVN) had Shares Outstanding of 65.30 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-04
- 2026-06-30: Shares outstanding (split-adjusted) 65.30M shares; Shares authorized (split-adjusted) (m).
- 2026-03-31: Shares outstanding (split-adjusted) 64.50M shares; Shares authorized (split-adjusted) (m).
- 2025-12-31: Shares outstanding (split-adjusted) 63.50M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 70.80M shares; Shares authorized (split-adjusted) (m).
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 65.30M shares 10-Q · filed 2026-08-04 | (m) |
| 2026-03-31 | 64.50M shares 10-Q · filed 2026-05-11 | (m) |
| 2025-12-31 | 63.50M shares 10-Q · filed 2026-08-04 | 200.00M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 70.80M shares 10-Q · filed 2025-11-05 | (m) |
| 2025-06-30 | 73.20M shares 10-Q · filed 2025-08-06 | (m) |
| 2025-03-31 | 73.00M shares 10-Q · filed 2025-05-01 | (m) |
| 2024-12-31 | 68.80M shares 10-K · filed 2026-02-24 | 200.00M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 68.70M shares 10-Q · filed 2024-10-30 | (m) |
| 2024-06-30 | 68.60M shares 10-Q · filed 2024-07-30 | (m) |
| 2024-03-31 | 68.30M shares 10-Q · filed 2024-05-07 | (m) |
| 2023-12-31 | 68.00M shares 10-K · filed 2025-02-11 | 200.00M shares 10-K · filed 2025-02-11 |
| 2023-09-30 | 55.00M shares 10-Q · filed 2023-11-07 | (m) |
| 2023-06-30 | 53.40M shares 10-Q · filed 2023-08-08 | (m) |
| 2023-03-31 | 53.40M shares 10-Q · filed 2023-05-05 | (m) |
| 2022-12-31 | 53.20M shares 10-K · filed 2024-02-27 | 200.00M shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 53.20M shares 10-Q · filed 2022-11-09 | (m) |
| 2022-06-30 | 53.20M shares 10-Q · filed 2022-08-04 | (m) |
| 2022-03-31 | 53.10M shares 10-Q · filed 2022-05-05 | (m) |
| 2021-12-31 | 53.00M shares 10-K · filed 2023-02-23 | 200.00M shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 52.77M shares 10-Q · filed 2021-11-03 | (m) |
| 2021-06-30 | 48.99M shares 10-Q · filed 2021-08-05 | (m) |
| 2021-03-31 | 48.79M shares 10-Q · filed 2021-05-04 | (m) |
| 2020-12-31 | 48.50M shares 10-K · filed 2022-02-28 | (m) |
| 2020-09-30 | 40.10M shares 10-Q · filed 2020-11-05 | (m) |
| 2020-06-30 | 38.83M shares 10-Q · filed 2020-08-04 | (m) |
| 2020-03-31 | 38.67M shares 10-Q · filed 2020-04-28 | (m) |
| 2019-12-31 | 38.46M shares 10-K · filed 2021-03-01 | (m) |
| 2019-09-30 | 33.08M shares 10-Q · filed 2019-11-04 | (m) |
| 2019-06-30 | 31.52M shares 10-Q · filed 2019-08-05 | (m) |
| 2019-03-31 | 31.37M shares 10-Q · filed 2019-05-09 | (m) |
| 2018-12-31 | 31.24M shares 10-K · filed 2020-03-16 | (m) |
| 2018-09-30 | 3.68M shares 10-Q · filed 2018-11-14 | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |